Abstract
Quality of life and health related quality of life among end-stage kidney disease patients: Methodology
Highlights
End-stage kidney disease (ESKD) is a serious and irreversible condition
A three-phase, cross-sectional, correlational study was conducted to explore the meaning of quality of life (QoL) and to determine factors affecting QoL and health related quality of life (HRQoL) in patients with ESKD
Phase-1 explored the conceptual basis of QoL and how that has been assessed in ESKD patients
Summary
End-stage kidney disease (ESKD) is a serious and irreversible condition. Understanding the impact of ESKD and its treatment on an individual's quality of life (QoL) is important. Alternative outcome measures of the efficacy of provided treatment and HD are required [4] This may be through assessing HRQoL which could be included when health care professionals assess the benefits of different ESKD treatment options. All socio-demographic data were classified according to the Oman norm, using the National Centre for Statistics and Information, Oman (2016) These data are detailed as follows: the category for marital status (single, married, widowed, divorced); level of education (illiterate, low-intermediate, intermediate, high-intermediate, high); employment status (employed or unemployed); and income, measured in Omani Rials (OMR), One Rial=£2.00 (< OMR 250/month; OMR 250-600/month; OMR 601-1000/month; OMR 1001-1500/month; OMR >1500/month). The treatment characteristics factors related to HD prescription which might affect patients’ HRQoL were collected by the background data sheet. The normal range values of these investigations are adopted from The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2007)
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call